ReviewEMBO reports2026
The ER-Golgi intermediate compartment: a central hub integrating membrane trafficking and stress responses.
Review in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The endoplasmic reticulum-Golgi intermediate compartment (ERGIC) is a dynamic membrane system at the ER-Golgi interface, traditionally viewed as a transient station for COPII- and COPI-dependent trafficking. Emerging evidence redefines the ERGIC as a stress-responsive regulatory hub that integrates membrane trafficking with cellular adaptation. In addition to coordinating bidirectional transport and cargo sorting, the ERGIC actively participates in protein quality control during ER stress and remodels trafficking flux under perturbations. It serves as a platform linking secretory pathways to stress signaling, contributing to autophagosome biogenesis, facilitating unconventional protein secretion under stress conditions, and modulating innate immune responses, including STING activation. The ERGIC is also co-opted by pathogens such as coronaviruses, underscoring its role at the interface of membrane remodeling and host defense. These functions position the ERGIC as a central integrator of trafficking dynamics and stress responses, whose structural plasticity enables rapid adaptation to physiological and pathological challenges.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.